Derek Cogan

Affiliations: 
1999 Boehringer Ingelheim 
Google:
"Derek Cogan"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Meyers K, Cogan DA, Burke J, et al. (2017) Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity. Bioorganic & Medicinal Chemistry Letters
Abeywardane A, Caviness G, Choi Y, et al. (2016) N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity. Bioorganic & Medicinal Chemistry Letters
Weldon SM, Cerny MA, Gueneva-Boucheva K, et al. (2016) Selectivity of BI 689648 - A Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison to FAD286 and LCI699 in Non-Human Primates. The Journal of Pharmacology and Experimental Therapeutics
Moss N, Xiong Z, Burke M, et al. (2012) Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement. Bioorganic & Medicinal Chemistry Letters. 22: 7189-93
Boyer SJ, Burke J, Guo X, et al. (2012) Indole RSK inhibitors. Part 1: discovery and initial SAR. Bioorganic & Medicinal Chemistry Letters. 22: 733-7
Moss N, Choi Y, Cogan D, et al. (2009) A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19: 2206-10
Xiong Z, Gao DA, Cogan DA, et al. (2008) Synthesis and SAR studies of indole-based MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 1994-9
Goldberg DR, Choi Y, Cogan D, et al. (2008) Pyrazinoindolone inhibitors of MAPKAP-K2. Bioorganic & Medicinal Chemistry Letters. 18: 938-41
Cywin CL, Dahmann G, Prokopowicz AS, et al. (2007) Discovery of potent and selective PKC-theta inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 225-30
See more...